Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 Update Clinical Practice Guideline

Details

• Corporate Authors:
  United States. Public Health Service. ; Centers for Disease Control and Prevention (U.S.) ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group.
• Description:
  The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure Prophylaxis forthe Prevention of HIV Infection in the United States – 2016: Update – A Clinical Practice Guideline includes revisions to several sections. These revisions are highlighted throughout the document and are intended solely to update the developing evidence base or to clarify specific points in clinical care. No changes were made to the graded recommendations for the use of PrEP in the US.
• Content Notes:
  Priya Jakhmola (CPY5@cdc.gov)
  
  4/20/2018
  
  
• Subjects:
  Anti-HIV Agents/therapeutic Use HIV Infections/epidemiology HIV Infections/prevention & Control Homosexuality, Male Pre-Exposure Prophylaxis Pregnancy Pregnancy Complications, Infectious/prevention & Control
• Document Type:
  Text
• Genre:
  Practice Guideline
• Pages in Document:
  77 numbered pages
• Collection(s):
  Guidelines and Recommendations
• Main Document Checksum:
  urn:sha-512:c8dd2508db3ef44c6f8b2c6d2b7fd91fc6cf818ffede4ab70a9b2363d1e5b8787641f16b0dfcb14b29ed4425173fc40b3446304e593065362dfea6be379672c0
• Download URL:
  https://stacks.cdc.gov/view/cdc/53509/cdc_53509_DS1.pdf
• File Type:
  [PDF - 1.67 MB ]